Do Pfizer, CDC see eye to eye on boosters? To view this email as a web page,
click here AstraZeneca kick-starts new COVID variant-busting vaccine test Pfizer, CDC experts don't see eye to eye on COVID-19 boosters, threatening key revenue stream: analysts Telehealth use falls 37% from pandemic highs, while demand for healthcare services projected to flatten: report Biden administration 'absolutely supportive' of efforts to expand virtual care, HHS official says COVID-19 tracker: Mixing Pfizer, AZ shots produces strong response, study finds; Dr. Reddy's launches new drug Featured Story | By Ben Adams AstraZeneca has come under a lot of slack for its perceived poor communication and weaker results than its mRNA rivals, but the U.K. Big Pharma is still gunning in the COVID vaccine R&D game as its steps up to beat back new variants. read more |
| |
|---|
|
| | Webinar: New Trends in Virtual Trials Monday, July 26 | 11am ET / 8am PT Last year, clinical trial platform developer Medable raised $91M in private funding, amid the COVID-19 pandemic that touched off huge demand among pharma companies looking to initiate “siteless” or virtual clinical trials. Explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now. |
Top Stories By Noah Higgins-Dunn Pfizer has predicted that a COVID-19 vaccine booster could be needed as soon as antibody blood concentration wanes to ensure the broad population can't carry the virus, Bernstein analysts wrote in a recent note. However, a key CDC panel doesn't appear to agree. read more By Heather Landi Future demand for healthcare services will be relatively flat to declining, with little to no effect from the COVID-19 pandemic, according to a new forecast report. At the same time, hospitals and health systems are facing increasing competition from consumer businesses such as Amazon and Walmart, retail behemoths that are rapidly expanding the supply of healthcare services. read more By Heather Landi President Joe Biden's top health official said the administration is "absolutely supportive" of efforts to expand telehealth flexibilities after the public health emergency expires. HHS also will ramp up oversight to ensure digital health and virtual care services are rolled out equitably across the country, HHS Secretary Xavier Becerra said. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner In a U.K. study, investigators found that mixing the COVID-19 vaccines from Pfizer and AstraZeneca produced a strong immune response. Plus, Dr. Reddy's Laboratories launched a new drug in India. And more. read more | | Webinar: COVID-19 Virus Sequencing for Drug Development Wednesday, July 28 | 10:30am ET / 7:30am PT As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now. |
|
|
